News

Federal Circuit Sides with J&J in Patent Battle over Schizophrenia Drug Regimen

By Nafsika Karavida and Lucia Mead Last week, in a significant win for Janssen Pharmaceuticals (a Johnson & Johnson company), the U.S. Court of Appeals for the Federal Circuit (“CAFC”) upheld the district court’s ruling in Janssen Pharmaceuticals Inc. v. Teva Pharmaceuticals USA Inc., affirming that Teva had failed to...

Read More

Daniel Ain Raises Title IX Concerns Over NCAA’s $2.8 Billion Athlete Compensation Settlement in an Article for “Business Insider”

In a recent article for Business Insider, RPJ’s Daniel Ain discusses the groundbreaking House v. NCAA $2.8 billion settlement and significant legal questions it may raise, particularly around gender equity and Title IX compliance.  The settlement, which marks a historic shift in college athletics, allows schools for the first time...

Read More